| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1499-3872(14)60001-1 |
| P698 | PubMed publication ID | 24463074 |
| P2093 | author name string | Ying Luo | |
| Sheng Ye | |||
| Jia-Hong Dong | |||
| Wei-Dong Duan | |||
| Wen-Bin Ji | |||
| P2860 | cites work | Donation after cardio-circulatory death liver transplantation | Q28728002 |
| Effects of 10 minutes of ischemic preconditioning of the cadaveric liver on the graft's preservation and function: the ying and the yang | Q33217692 | ||
| A histometric analysis of chronically rejected human liver allografts: insights into the mechanisms of bile duct loss: direct immunologic and ischemic factors | Q34207045 | ||
| Increased bile duct complications in liver transplantation across the ABO barrier | Q34351946 | ||
| Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center | Q35010160 | ||
| De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients | Q35535173 | ||
| Ischemic preconditioning: enough evidence to support clinical application in liver surgery and transplantation? | Q35599220 | ||
| Management of biliary tract complications after orthotopic liver transplantation. | Q35933781 | ||
| THE HISTOLOGICAL DISTRIBUTION OF THE BLOOD GROUP SUBSTANCES IN MAN AS DISCLOSED BY IMMUNOFLUORESCENCE : II. THE H ANTIGEN AND ITS RELATION TO A AND B ANTIGENS. | Q36265918 | ||
| Liver transplantation from donation after cardiac death: a single center experience | Q36879002 | ||
| Biliary tract complications after liver transplantation: a review | Q37217187 | ||
| The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: the untold story | Q37466276 | ||
| Blood group antigens in the intrahepatic biliary tree. I. Distribution in the normal liver | Q41287246 | ||
| Liver transplantation across ABO blood group barriers | Q42074318 | ||
| Biliary strictures complicating liver transplantation. Incidence, pathogenesis, management, and outcome | Q42110243 | ||
| Cholangiographic findings in hepatic artery occlusion after liver transplantation | Q42144471 | ||
| Evaluation of protocol before transplantation and after reperfusion biopsies from human orthotopic liver allografts: considerations of preservation and early immunological injury | Q42574211 | ||
| Incidence of and risk factors for ischemic-type biliary lesions following orthotopic liver transplantation | Q43289662 | ||
| Type of donor aortic preservation solution and not cold ischemia time is a major determinant of biliary strictures after liver transplantation | Q43666890 | ||
| Biliary complications after liver transplantation using grafts from donors after cardiac death: results from a matched control study in a single large volume center | Q44183494 | ||
| Prevention of ischemic-type biliary lesions by arterial back-table pressure perfusion | Q44347307 | ||
| Similar liver transplantation survival with selected cardiac death donors and brain death donors | Q44432801 | ||
| Cytomegalovirus infection and development of biliary complications after liver transplantation | Q44481007 | ||
| Effects of anti-inflammatory cytokine agent (FR167653) and serine protease inhibitor on warm ischemia-reperfusion injury of the liver graft | Q44967954 | ||
| Liver transplantation from controlled non-heart-beating donors: an increased incidence of biliary complications | Q45083252 | ||
| Rapid increase of bile salt secretion is associated with bile duct injury after human liver transplantation. | Q45175716 | ||
| Liver transplantation using donation after cardiac death donors: long-term follow-up from a single center | Q46122261 | ||
| Events in procurement as risk factors for ischemic cholangiopathy in liver transplantation using donation after cardiac death donors | Q46222675 | ||
| The increased costs of donation after cardiac death liver transplantation: caveat emptor | Q48274931 | ||
| Bile duct strictures after hepatobiliary surgery: assessment with MR cholangiography | Q50164723 | ||
| Effects of cold ischemia time on the graft after orthotopic liver transplantation. A bile cytological study | Q50167424 | ||
| Optimized endoscopic treatment of ischemic-type biliary lesions after liver transplantation. | Q50919196 | ||
| The importance of portal venous blood flow in ischemic-type biliary lesions after liver transplantation. | Q51049368 | ||
| Endogenous bile salts are associated with bile duct injury in the rat liver transplantation model. | Q51832568 | ||
| Outcome of post-liver transplant ischemic and nonischemic biliary stenoses treated with percutaneous interventions: the Bologna experience | Q56982852 | ||
| Bile salt toxicity aggravates cold ischemic injury of bile ducts after liver transplantation inMdr2+/− mice | Q57547003 | ||
| Who Pays for Biliary Complications Following Liver Transplant? A Business Case for Quality Improvement | Q57653172 | ||
| Detection of biliary complications after orthotopic liver transplantation with MR cholangiography | Q57943802 | ||
| l-ARGININE REDUCES LIVER AND BILIARY TRACT DAMAGE AFTER LIVER TRANSPLANTATION FROM NON-HEART-BEATING DONOR PIGS1 | Q59632712 | ||
| Cytomegalovirus infection persists in the liver graft in the vanishing bile duct syndrome | Q67493028 | ||
| Ischemic cholangitis in hepatic allografts | Q67582038 | ||
| Diffuse biliary tract injury after orthotopic liver transplantation | Q67586757 | ||
| Ischemic-type biliary complications after orthotopic liver transplantation | Q68184067 | ||
| Clinical patterns of cytomegalovirus disease after liver transplantation | Q69360627 | ||
| Expression of blood group-related antigens in the intrahepatic biliary tree and hepatocytes in normal livers and various hepatobiliary diseases | Q69651172 | ||
| Diagnostic features and clinical outcome of ischemic-type biliary complications after liver transplantation | Q70670258 | ||
| Reperfusion damage to the bile canaliculi in transplanted human liver | Q71748711 | ||
| Evidence of preservation injury to bile ducts by bile salts in the pig and its prevention by infusions of hydrophilic bile salts | Q72131192 | ||
| Intrahepatic biliary strictures after liver transplantation | Q72421841 | ||
| In vitro induction of endothelial HLA class II antigen expression by cytomegalovirus-activated CD4+ T cells | Q72663292 | ||
| The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation | Q72747680 | ||
| Liver transplantation from controlled non-heart-beating donors | Q73030034 | ||
| Hepatropic soluble vitamin E derivative EPC-K1 prevents warm ischemia/reperfusion injury of non-heart-beating donor liver transplantation in pigs | Q73279021 | ||
| Risk factors for and clinical course of non-anastomotic biliary strictures after liver transplantation | Q73546997 | ||
| Role of endothelins and nitric oxide in hepatic reperfusion injury in the rat | Q74310605 | ||
| Cytomegalovirus infection is associated with increased inflammation and severe bile duct damage in rat liver allografts | Q74428419 | ||
| Prolonged hepatic warm ischemia in non-heart-beating donors: protective effects of FK506 and a platelet activating factor antagonist in porcine liver transplantation | Q74646506 | ||
| Reorganization of cholangiocyte membrane domains represents an early event in rat liver ischemia | Q77363651 | ||
| Biliary tract complications after orthotopic liver transplantation with choledochocholedochostomy anastomosis: endoscopic findings and results of therapy | Q77571232 | ||
| Reconstructive surgery for ischemic-type lesions at the bile duct bifurcation after liver transplantation | Q77922728 | ||
| Liver transplantation from Maastricht category 2 non-heart-beating donors | Q79162217 | ||
| Endoscopic Management of Biliary Complications After Orthotopic Liver Transplantation | Q79222557 | ||
| Biliary epithelial cell antibodies induce expression of toll-like receptors 2 and 3: a mechanism for post-liver transplantation cholangitis? | Q80407231 | ||
| Biliary complications after liver transplantation from maastricht category-2 non-heart-beating donors | Q80487613 | ||
| Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors | Q81262123 | ||
| Magnetic resonance cholangiopancreatography for the accurate diagnosis of biliary complications after liver transplantation: comparison with endoscopic retrograde cholangiography and percutaneous transhepatic cholangiography - long-term follow-up | Q82256306 | ||
| Liver allograft antibody-mediated rejection with demonstration of sinusoidal C4d staining and circulating donor-specific antibodies | Q83739286 | ||
| Histological examination and evaluation of donor bile ducts received during orthotopic liver transplantation--a morphological clue to ischemic-type biliary lesion? | Q84139715 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 10-17 | |
| P577 | publication date | 2014-02-01 | |
| P1433 | published in | Hepatobiliary & Pancreatic Diseases International | Q26841832 |
| P1476 | title | Graft cholangiopathy: etiology, diagnosis, and therapeutic strategies | |
| P478 | volume | 13 |
| Q96348268 | Inhibition of miR-450b-5p ameliorates hepatic ischemia/reperfusion injury via targeting CRYAB |
| Q59134574 | Ischemic Cholangiopathy 11 Years after Liver Transplantation from Asymptomatic Chronic Hepatic Artery Thrombosis |
| Q35651549 | Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease |
| Q53670571 | Tauroursodeoxycholic acid and 4-phenyl butyric acid alleviate endoplasmic reticulum stress and improve prognosis of donation after cardiac death liver transplantation in rats. |
Search more.